natgillin/translations-raw huggingface dataset:
Gently press on the base of the bottle to release one drop of NEVANAC at a time.
Laganim pritiskom na dno bočice istisnite po jednu kap NEVANAC-a.
Gently press on the base of the bottle to release one drop of OPATANOL at a time.
Laganim pritiskom kažiprsta na dno okrenute bočice istisnite po jednu kapljicu lijeka OPATANOL.
Gently press on the base of the bottle to release one drop of SIMBRINZA at a time.
Nježno pritisnite dno boce tako da svaki puta istekne samo jedna kap SIMBRINZE.
Gently pull back the plunger of the syringe.
Lagano povucite klip štrcaljke.
Gently pull back the plunger to check if blood is aspirated.
Laganim povlačenjem klipa štrcaljke prema natrag, provjerite da krv nije aspirirana.
Gently pull down the lower eyelid to form a pocket.
Pažljivo povucite donju vjeđu dok se ne stvori mali džep.
Gently pull your penis away from your body to its full length and hold the stretch for 30 seconds.
Nježno vucite penis od tijela dok ne dosegne punu duljinu i držite ga istegnutog 30 sekundi.
Gently push the injection needle onto the pen as shown in Diagram E. (Notice that the rear portion of the injection needle will pierce through the rubber membrane that you disinfected previously).
Nježno pritisnite iglu za injekciju na brizgalicu, kako je prikazano na Dijagramu E. (Zamijetit ćete da će stražnji dio igle za injekciju probiti gumenu opnu koju ste prethodno dezinficirali).
Gently push the plunger all the way down until air is injected into the vial.
Lagano gurnite klip do kraja dok se zrak ne ubrizga u bočicu.
Gently push the tablet out.
Nježno istisnite tabletu .
Gently remove surgical gauze or laparotomy pads from the application site, without disrupting or dislodging EVARREST or the clot.
Nježno skinite kiruršku gazu ili laparotomijske jastučiće s mjesta primjene bez pomicanja ili odvajanja lijeka EVARREST ili ugruška.
Gently remove the tablet (Figure 2).
Pažljivo izvadite tabletu (Slika 2).
Gently roll the pen 10 times.
Nježno rotirajte brizgalicu 10 puta.
Gently roll the Pen 10 times.
Nježno rotirajte brizgalicu među dlanovima 10 puta.
Gently roll the vial between your palms for about 15 seconds.
Nježno vrtite bočicu između dlanova oko 15 sekundi.
Gently rotate the pre-filled pen back and forth a few times to mix the medicine.
Nježno naginjite napunjenu brizgalicu nekoliko puta naprijed-natrag kako bi izmiješali lijek.
Gently rub the gel onto the treatment area.
Nježno utrljajte gel na liječeno područje.
Gently screw the syringe on to the powder vial (B).
Nježno pričvrstite štrcaljku zavrtanjem na bočicu s praškom (B).
Gently screw the syringe onto the vial adapter.
Lagano navijte štrcaljku na nastavak za bočicu.
Gently set the vial with vial adapter down on your clean work surface.
Pažljivo odložite bočicu s nastavkom na Vašu čistu radnu površinu.
Gently shake the bag to mix the antigen suspension with the diluent.
Lagano protresite vrećicu da se umiješa antigen suspenzija u otapalu.
Gently shake the single dose container prior to use
Prije primjene nježno protresite jednodozni spremnik.
Gently squeeze one drop of the medicine onto your eye.
Nježno istisnite jednu kap lijeka u oko.
Gently squeeze the bottle to release one drop of DuoTrav at a time (picture 3).
Lagano stisnite bočicu, tako da isteče po jedna kap lijeka DuoTrav (slika 3).
Gently squeeze the bottle to release one drop of IZBA at a time. (picture 3)
Lagano stisnite bočicu, tako da istisnete po jednu kap IZBE (slika 3).
Gently squeeze the bottle to release one drop of TRAVATAN at a time. (picture 3)
Lagano stisnite bočicu tako da isteče po jedna kap lijeka TRAVATAN (slika 3)
Gently squeeze the bottle to release one drop of Yellox.
Nježno stisnite bočicu za ispuštanje jedne kapi Yelloxa.
Gently squeeze the container to release one drop into the pocket between the eyelid and eye (picture 3).
Nježno stisnite spremnik, da oslobodite jednu kap u džep između vjeđe i oka (slika 3).
Gently squeeze the sides of the bottle until one drop is released into your eye (picture 2).
Lagano pritisnite stranice bočice sve dok ne istisnete jednu kap u oko (slika 2).
Gently straighten your penis one time a day.
Nježno ispravljajte svoj penis jedanput na dan.
Gently stretch your penis 3 times a day.
Nježno istegnite svoj penis 3 puta na dan.
Gently swirl the contents in the vial until all materials are dissolved; DO NOT SHAKE.
Bočicu sa sadržajem pažljivo vrtite dok se sav prašak ne otopi; NEMOJTE TRESTI.
Gently swirl the liquid, sliding the vial in a circular motion on a flat surface.
Lagano promiješajte tekućinu, klizeći bočicom kružnim pokretom po ravnoj površini.
Gently swirl the powder vial until all powder is dissolved.
Laganim kružnim pokretima okrećite bočicu sve dok se sav prašak ne otopi.
Gently swirl the powder vial until the powder is completely dissolved.
Nježno vrtite bočicu s praškom sve dok se prašak potpuno ne otopi.
Gently swirl the product vial with the transparent adapter attached until the substance is fully dissolved.
Lagano okrećite bočicu s lijekom i pričvršćenim prozirnim nastavkom sve dok se prašak potpuno ne otopi.
Gently swirl the vial until all the powder has dissolved.
Nježno vrtite bočicu sve dok se sav prašak ne otopi.
Gently swirl the vial until all the powder is dissolved.
Nježno vrtite bočicu dok se sav prašak ne otopi.
Gently swirl to facilitate complete dissolution of the powder.
Pažljivo vrtite kako biste omogućili potpuno otapanje praška.
Gently swirl.
Lagano okrećite.
Gently swirl.
Nježno okrećite.
Gently tap the syringe barrel with your fingers until the air bubble/gap rises to the top of the syringe.
lagano lupkajte po tijelu štrcaljke s prstima sve dok se mjehurić zraka/praznina ne podignu do vrha štrcaljke.
Gently tap the syringe so the large air bubbles rise to the top.
Lagano kucnite štrcaljku kako bi se veliki mjehurići zraka podigli na vrh.
Gently tap the syringe to make any bubbles rise to the top of the syringe, near the needle (see Diagram 10).
Nježno kucnite po štrcaljki kako bi se mjehurići zraka podigli prema vrhu, blizu igle (vidjeti sliku 10).
Gently tap to bring air bubbles to the top.
Nježno lupkajte tako da mjehurići zraka odu na vrh.
Gently turn the dose setting knob clockwise until it reads 25 in the Dose Feedback Window.
Pažljivo okrenite gumb za podešavanje doze u smjeru kazaljke na satu sve dok se na prozorčiću za prikaz doze ne pojavi 25.
Gently turn the dose setting knob clockwise.
Lagano okrenite tipku za podešavanje doze u smjeru kazaljke na satu.
Gently turn the vial upside down.
Nježno preokrenite bočicu.
Gently wash the area with soap and water to remove it.
Nježno operite područje sapunom i vodom kako biste ga uklonili.
Gently washing the area with warm water and mild soap should remove any adhesive that stays on your skin after you remove the patch.
Područje nježno operite toplom vodom i blagim sapunom kako bi uklonili tragove ljepila na koži koji su ostali po odstranjivanju flastera.
Gently withdraw the contents of the ampoule into a sterile syringe, mounted with an 18 gauge needle.
Polako povući sadržaj ampule u sterilnu brizgalicu s iglom18 gauge.
Gently, turn the needle clockwise until it is firmly attached, otherwise the needle may leak.
Pažljivo okrenite iglu u smjeru kazaljke na satu sve dok nije dobro učvršćena jer u suprotnom bi igla mogla propuštati tekućinu.
Genuair inhaler there are 2 steps patients need to perform after removing the cap.
Nakon skidanja kapice, bolesnici moraju provesti 2 koraka kako bi upotrijebili Genuair inhalator.
Genvoya 150 mg/150 mg/200 mg/10 mg film-coated tablets
Genvoya 150 mg/150 mg/200 mg/10 mg filmom obložene tablete elvitegravir/kobicistat/emtricitabin/tenofoviralafenamid
Genvoya [Outer packaging only]
Genvoya [samo vanjsko pakiranje]
Genvoya does not cure HIV-1 infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Genvoya ne liječi infekciju virusom HIV-1 niti AIDS, no može odgoditi oštećenje imunološkog sustava i razvoj infekcija i bolesti povezanih s AIDS-om.
Genvoya is a single tablet for the treatment of human immunodeficiency virus 1 (HIV-1) infection in adults and adolescents 12 years of age and older, who weigh at least 35 kg.
Genvoya je jedna tableta za liječenje infekcije virusom humane imunodeficijencije 1 (HIV-1) u odraslih i adolescenata u dobi od 12 godina i starijih, koji imaju tjelesnu težinu od najmanje 35 kg.
Genvoya is an antiviral medicine used to treat individuals infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Genvoya je antivirusni lijek koji se koristi za liječenje bolesnika zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1), virusom koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
Genvoya is available as tablets, each containing 150 mg elvitegravir, 150 mg cobicistat, 200 mg emtricitabine and 10 mg tenofovir alafenamide.
Lijek Genvoya dostupan je u obliku tableta koje sadrže 150 mg elvitegravira, 150 mg kobicistata, 200 mg emtricitabina i 10 mg tenofoviralafenamida.
Genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus-1 (HIV-1) without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir (see sections 4.2 and 5.1).
Genvoya je indicirana za liječenje odraslih osoba i adolescenata (u dobi od 12 godina i starijih, s tjelesnom težinom od najmanje 35 kg) zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1) bez ijedne poznate mutacije povezane s rezistencijom na skupinu inhibitora integraze, emtricitabin ili tenofovir (vidjeti dijelove 4.2 i 5.1).
Genvoya met the non-inferiority criteria in achieving HIV-1 RNA < 50 copies/mL when compared to E/C/F/TDF.
U usporedbi sa skupinom E/C/F/TDF, lijek Genvoya je ispunio kriterije neinferiornosti u postizanju vrijednosti HIV-1 RNK < 50 kopija/ml.
Genvoya reduces the amount of HIV in your body.
Genvoya smanjuje količinu HIV-a u Vašem tijelu.
Genvoya should be discontinued in patients with estimated CrCl that declines below 30 mL/min during treatment (see sections 5.1 and 5.2).
Potrebno je prekinuti liječenje lijekom Genvoya u bolesnika u kojih procijenjeni CrCl tijekom liječenja opada na vrijednosti ispod 30 ml/min (vidjeti dijelove 5.1 i 5.2).
Genvoya should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Genvoya se smije primjenjivati tijekom trudnoće samo ako moguća korist opravdava mogući rizik za fetus.
Genvoya should not be administered concomitantly with medicinal products containing tenofovir disoproxil (as fumarate), lamivudine or adefovir dipivoxil used for the treatment of HBV infection.
Genvoya se ne smije primjenjivati istodobno s lijekovima koji sadržavaju tenofovirdizoproksil (u obliku fumarata), lamivudin ili adefovirdipivoksil koji se primjenjuju za liječenje infekcije HBV-om.
Genvoya should not be administered concomitantly with medicinal products containing tenofovir disoproxil (as fumarate), lamivudine or adefovir dipivoxil used for the treatment of HBV infection.
Genvoya se ne smije primjenjivati istodobno s lijekovima koji sadrže tenofovirdizoproksil (u obliku fumarata), lamivudin ili adefovirdipivoksil koji se primjenjuju u liječenju infekcije HBV-om.
Genvoya should not be co-administered with colchicine to patients with renal or hepatic impairment.
Bolesnicima s oštećenjem funkcije bubrega ili jetre Genvoya se ne smije istodobno davati s kolhicinom.
Genvoya should not be initiated in patients with estimated CrCl < 30 mL/min as there are limited data available regarding the use of Genvoya in this population (see sections 5.1 and 5.2).
Primjena lijeka Genvoya se ne smije započeti u bolesnika s procijenjenim CrCl < 30 ml/min budući da su podaci o primjeni lijeka Genvoya u ovoj populaciji ograničeni (vidjeti dijelove 5.1 i 5.2).
Genvoya was investigated in two main studies involving 1,733 adults infected with HIV-1 who had not been treated previously.
Lijek Genvoya ispitan je u dvama glavnim ispitivanjima koja su obuhvatila 1733 odrasla bolesnika zaražena virusom HIV-1 koji prethodno nisu bili liječeni.
Genvoya’s side effects were similar to those of the individual medicines.
Nuspojave lijeka Genvoya bile su slične onima pojedinačnih lijekova.
Genzyme Biosurgery ApS, Oliefabriksvej 51B, DK-2770 Kastrup, Denmark
Genzyme Biosurgery ApS, Oliefabriksvej 51B, DK-2770 Kastrup, Danska
Genzyme Corporation, 500 Soldiers Field Road, Allston, MA 02134, USA
Genzyme Corporation, 500 Soldiers Field Road, Allston, MA 02134, SAD
Genzyme Europe B.V. - NL Store in a refrigerator.
Genzyme Europe B.V. - NL Čuvati u hladnjaku.
Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, the Netherlands
Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, 1411 DD, Naarden, the Netherlands
Genzyme Europe B.V., Gooimeer 10, 1411 DD, Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, 1411DD, Naarden, The Netherlands
Genzyme Europe B.V., Gooimeer 10, 1411DD, Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands
Genzyme Europe B.V., Gooimeer 10, NL-1411DD Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands.
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, Nizozemska.
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD, Naarden, The Netherlands
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD, Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD, Naarden, The Netherlands
Genzyme Europe, B.V., Gooimer 10, NL-1411 DD, Naarden, Nizozemska
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD, Naarden, The Netherlands.
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD, Naarden, Nizozemska.
Genzyme Europe B.V., Gooimeer 10, NL-1411DD Naarden, The Netherlands
Genzyme Europe B.V., Gooimeer 10, NL-1411DD Naarden, Nizozemska.
Genzyme Europe BV Gooimeer 10 1411DD Naarden The Netherlands
Genzyme Europe BV Gooimeer 10 1411DD Naarden Nizozemska
Genzyme Ireland Limited, IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland.
Genzyme Ireland Limited, IDA Industrial Park, Old Kilmeaden Road, Waterford, Irska
Genzyme Limited 37 Hollands Road Suffolk
37 Hollands Road Suffolk
Genzyme Limited, 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland
Genzyme Limited, 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Irska
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Ujedinjeno Kraljevstvo
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija.
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Irska
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland‌
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Ujedinjeno Kraljevstvo Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Irska
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom.
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Ujedinjeno Kraljevstvo.
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom.
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom.
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Velika Britanija.
Genzyme Therapeutics Ltd, 4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, United Kingdom
Genzyme Therapeutics Ltd, 4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU, Velika Britanija
Geometric mean (%CV) clearance was 7.79 (25%) L/hr/m2, volume of distribution at steady-state was 834 (39%) L/m2, and the elimination half-life was 100 (44%) hours.
Geometrijska sredina (%CV) klirensa bila je 7,79 (25%) l/h/m2, volumen distribucije u stanju dinamičke ravnoteže bio je 834 (39%) l/m2, i poluvijek eliminacije bio je 100 (44%) sati.
Geometric mean (%CV†)
Geometrijska srednja vrijednost (%CV†)
Geometric mean change (%)
Geometrijska sredina promjene (%)
Geometric mean change (%)
Promjena geometrijske srednje vrijednosti (%)
Geometric mean change (%) (Possible mechanism)
Geometrijska sredina promjene (%) (Mogući mehanizam)
Geometric Mean Change (%) in
Geometrijska sredina promjene
Geometric Mean Change (%) in
inkopu, promjene vida i produženu
Geometric mean changes (%)
Promjene geometrijske sredine (%)
Geometric mean of titre (1/dil)
Srednji geometrijski
Geometric mean of titre (1/dil)
Srednji geometrijski titar (1/dil)
Geometric mean of titre ratio (GMTR)
Omjer geometrijskog
Geometric mean of titre ratio (GMTR)
Omjer geometrijskog srednjeg titra (GMTR)
Geometric mean steady-state dapagliflozin Cmax and AUCτ values following once daily 10 mg doses of dapagliflozin were 158 ng/ml and 628 ng h/ml, respectively.
Geometrijska sredina vrijednosti Cmax i AUCτ dapagliflozina u stanju dinamičke ravnoteže nakon primjene doza dapagliflozina od 10 mg jedanput na dan iznosile su 158 ng/ml odnosno
Geometric mean steady-state plasma Viramune prolonged-release pre-dose trough concentrations were 3,880 ng/ml, 3,310 ng/ml and 5,350 ng/ml in age groups 3 to <6 years, 6 to <12 years, and 12 to <18 years of age, respectively.
Geometrijski prosjek doze na kraju dozirnog intervala Viramunea s produljenim oslobađanjem u plazmi pri stanju dinamičke ravnoteže bio je 3880 ng/ml, 3310 ng/ml odnosno 5350 ng/ml u dobnim skupinama 3 do <6 godina, 6 do <12 godina, i 12 do <18 godina starosti.
Geometric mean titer (by plaque reduction neutralization test)
Geometrijska sredina titra (prema testu neutralizacije redukcije plaka)
Geometric mean topotecan lactone dose-normalized AUC(0-) values for Korean patients were 7.9, 12.9 and 19.7 ng*h/mL in subjects with creatinine clearance values of more than 80 mL/min, 50 to 80 mL/min and 30 to 49 mL/min, respectively (see section 4.2 and 4.4).
Geometrijska srednja vrijednost AUC(0-) topotekan laktona normalizirana prema dozi u bolesnika korejskog podrijetla iznosila je 7,9 ng*h/ml u ispitanika s klirensom kreatinina većim od 80 ml/min, 12,9 ng*h/ml u ispitanika s klirensom kreatinina od 50-80 ml/min i 19,7 ng*h/ml u ispitanika s klirensom kreatinina od 30-49 ml/min (vidjeti dijelove 4.2 i 4.4).
Geometric mean topotecan lactone dose-normalized AUC(0-) values were 9.4, 11.1 and 12.0 ng*h/mL in subjects with creatinine clearance values of more than 80 mL/min, 50 to 80 mL/min and 30 to 49 mL/min, respectively.
Geometrijska srednja vrijednost AUC(0-) topotekan laktona normalizirana prema dozi iznosila je 9,4 ng*h/ml u ispitanika s klirensom kreatinina većim od 80 ml/min, 11,1 ng*h/ml u ispitanika s klirensom kreatinina od 50 80 ml/min i 12,0 ng*h/ml u ispitanika s klirensom kreatinina od 30-49 ml/min.
Geometric mean topotecan lactone dose-normalized AUC(0-) values were 9.4, 11.1 and 12.0 ng*h/mL in subjects with creatinine clearance values of more than 80 mL/min, 50 to 80 mL/min and 30 to 49 mL/min, respectively.
Geometrijska srednja vrijednost AUC(0-) topotekan laktona normalizirana prema dozi iznosila je 9,4 ng*h/ml u ispitanika s klirensom kreatinina većim od 80 ml/min, 11,1 ng*h/ml u ispitanika s klirensom kreatinina od 50-80 ml/min i 12,0 ng*h/ml u ispitanika s klirensom kreatinina od 30-49 ml/min.
Geometric Mean ± Standard Deviation
Geometrijska srednja vrijednost ± standardna devijacija
Geometric Standard Deviation ±SD
Geometrijska standardna devijacija ±SD
Geriatric
Gerijatrijski bolesnici
Geriatric patients  65 years
Stariji bolesnici  65 godina
Geriatric population
Starija populacija
Geriatric use
Primjena u starijih bolesnika
Geriatric Use
Primjena u starijih osoba
GERM CELL TUMOURS
TUMOR ZAMETNIH STANICA
GERM CELL TUMOURS
TUMORI ZAMETNIH STANICA
Germ-free (aseptic) infusion techniques,
tehnikama infuzije bez mikroba (aseptičke);
Germany/ Deutschland Cardiome UK Limited Tel: +49 (0)69 33 29 62 76
Njemačka/Deutschland Cardiome UK Limited Tel: +49 (0)69 33 29 62 76
Gestational age below 24 or over 33 completed weeks
Gestacijska dob ispod 24 ili iznad 33 navršena tjedna
Get a good start!
Dobro se pripremite za početak
Get a new needle - only use the "single-use" needles supplied.
Uzmite novu iglu – koristite samo priložene igle „za jednokratnu primjenu“.
Get a new one.
Nabavite novu brizgalicu.
Get advice from a doctor or pharmacist if you take medicines used to treat stomach ulcers, heartburn or acid reflux as they can decrease the amount of velpatasvir in your blood.
Potražite savjet liječnika ili ljekarnika ako uzimate lijekove koji se primjenjuju za liječenje želučanog vrijeda, žgaravice ili povrata želučane kiseline jer oni mogu smanjiti količinu velpatasvira u Vašoj krvi.
Get an infection and/or a fever.
dobijete infekciju i/ili vrućicu.
get an infection or a fever have not used enough Xultophy, keep using less Xultophy than you need, forget to use Xultophy or stop using Xultophy without talking to your doctor.
dobijete infekciju ili vrućicu niste primijenili dovoljno lijeka Xultophy; primjenjujete manje lijeka Xultophy nego što Vam je potrebno; zaboravite primijeniti Xultophy ili prestanete primjenjivati Xultophy bez prethodnog razgovora s liječnikom.
Get in a semi-sitting position and try to relax
Zauzmite polusjedeći položaj i pokušajte se opustiti
Get in a semi-sitting position and try to relax.
Zauzmite polusjedeći položaj i pokušajte se opustiti.
get left upper belly (abdominal) pain, pain below the left rib cage or at the tip of your left shoulder (these may be symptoms of an enlarged spleen (splenomegaly), or possibly rupture of the spleen),
Vam se pojavi bol u lijevom gornjem dijelu trbuha (abdomena), bol ispod lijevog rebrenog luka ili u vrhu lijevog ramena (to mogu biti simptomi povećane slezene (splenomegalije) ili možda i puknuća (rupture) slezene),
get left upper belly (abdominal) pain, pain below the left rib cage or at the tip of your left shoulder [these may be symptoms of an enlarged spleen (splenomegaly), or possibly rupture of the spleen],
osjetite bol u gornjoj lijevoj strani trbuha (abdomena), bol na lijevoj strani ispod rebara ili u vrhu lijevog ramena [to mogu biti simptomi povećanja slezene (splenomegalije) ili mogućeg puknuća (rupture) slezene]
Get left upper belly (abdominal) pain, pain below the left rib cage or at the tip of your left shoulder( these may be symptoms of enlarge spleen or possibly rupture of spleen.
osjetite bol u gornjem dijelu trbuha (abdomena), bol ispod lijeve strane prsnog koša ili na vrhu lijevog ramena (to mogu biti simptomi povećane slezene ili rupture slezene.
Get medical help immediately if you get the following symptoms, as they may be signs of a heart attack or decreased blood flow to the heart: chest discomfort or pain which may spread beyond your chest to your shoulders, arms, back, neck, teeth, jaw or stomach and may come and go; shortness of breath; sudden outbreak into a sweat with cold, clammy skin, feeling dizzy or fainting
Odmah potražite liječničku pomoć ako razvijete sljedeće simptome jer oni mogu biti znak srčanog udara ili smanjenog protoka krvi kroz srce: nelagoda u prsima ili bol u prsima koja se može širiti izvan Vaših prsa u ramena, ruke, leđa, vrat, zube, čeljust ili želudac te može biti prolazna; nedostatak zraka; iznenadni napadaji znojenja s hladnom, ljepljivom kožom, vrtoglavica ili nesvjestica.
Get medical help immediately if you get the following symptoms:
Odmah potražite liječničku pomoć ako razvijete sljedeće simptome: